Journal article
Oral budesonide for induction of remission in ulcerative colitis
Abstract
BACKGROUND: Corticosteroids are first-line therapy for induction of remission in ulcerative colitis. Although corticosteroids may improve symptoms, they have significant adverse effects. Steroids which act topically, with less systemic side-effects may be more desirable. Budesonide is a topically acting corticosteroid with extensive first pass hepatic metabolism. There are currently three formulations of budesonide: two standard formulations …
Authors
Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
Journal
Cochrane Database of Systematic Reviews, Vol. 2015, No. 10,
Publisher
Wiley
DOI
10.1002/14651858.cd007698.pub3
ISSN
1361-6137